Immunic's promising results in MS patients with vidofludimus calcium #shorts

Stats For Nerds

Video id : rv0W5nmuun4
ImmersiveAmbientModecolor: #c4bfbf (color 2)
Video Format : 136 (720p) mp4 | h264 | 44100Hz | 750342 bps
Audio Format: 140 (AUDIO_QUALITY_MEDIUM) m4a | aac | 44100hz | STEREO(2channels)
PokeEncryptID: 869355617b869cc75aa547fc7eb726b063f60dbea0cc13f89e8ecdd1a3037dfeff939e32e4d9de76095540b506ec19d2
Proxy/Companion URL : woke-proxy.
Date : 1759870588440 - unknown on Apple WebKit
Mystery text?? : cnYwVzVubXV1bjQgaSAgbG92ICB1IHdva2UtcHJveHkucG9rZXR1YmUuZnVu
143 : true

Jump to Connections

Proactive Investors

62.9K subs

Download

PokeTranslate

18 Views • 2 months ago • Click to toggle off description

open dyslexic mode

Immunic Inc CEO Dr Daniel Vitt shares updates on the company’s multiple sclerosis clinical programs, including trial results, patient outcomes, and progress towards new treatment options.

#multiplesclerosis #Neuroprotection #DisabilityProgression #CALLIPERStudy #MedicalBreakthrough #ProgressiveMS #Immunic #VidofludimusCalcium #MSResearch #CALLIPERStudy #ENSURETrial #Neuroprotection #BiotechNews #PharmaUpdates #ClinicalTrials

Metadata And Engagement

Views : 18
Genre: News & Politics
License: Standard YouTube License

Uploaded At 2 months ago ^^
warning: returnyoutubedislikes may not be accurate, this is just an estiment ehe :3
Rating : 0 (0/0 LTDR)

0% of the users lieked the video!!
0% of the users dislieked the video!!
User score: 0.00- Overwhelmingly Negative

RYD date created : 2025-08-08T12:47:53.698551Z
See in json

Connections

0 Comments